The Role of Flavonoids in Glycemic Control and Diabetic Complications: Current Evidence and Future Directions

ABSTRACT Worldwide, diabetes and its consequences pose a significant threat to public health. The pathogenesis, molecular mechanisms, and complications are well identified, but their permanent cure is unknown. Plants have various compounds like flavonoids, alkaloids, and phytosterols, which work efficiently in anti‐diabetic roles. Flavonoids (flavanones, flavones, flavonols, isoflavones, anthocyanins, etc.) are a diverse group of polyphenolic compounds abundant in vegetables, fruits, and medicinal plants, demonstrating significant potential in glycemic control through a multifaceted mechanism. Current evidence demonstrates that flavonoids exert multifaceted antidiabetic effects through various mechanisms, including enhancement of insulin sensitivity, glucose uptake stimulation, and pancreatic β‐cell protection. Compounds such as quercetin, catechin, naringenin, and epicatechin have shown significant improvements in glycemic parameters and antioxidant enzymes in both preclinical and clinical studies. The compounds also show promise in preventing diabetic nephropathy through their anti‐inflammatory and antioxidant properties. Due to the adverse effects of various anti‐diabetic medications, researchers are looking for effective organic, plant‐based medicinal products that have negligible side effects. However, challenges remain regarding bioavailability, optimal dosing, and safety profiles, particularly in vulnerable populations, including pregnant women. Future directions should prioritize nano‐formulations to improve pharmacokinetics. The integration of multi‐omics approaches could further elucidate flavonoid‐mediated epigenetic modifications in chronic diabetic complications. More rigorous and larger‐scale clinical trials are required to validate their efficacy, determine appropriate dosing, and assess long‐term safety.